Literature DB >> 2852948

Psychosocial well-being of patients with inoperable non-small cell lung cancer. The importance of treatment- and disease-related factors.

S Kaasa1, A Mastekaasa.   

Abstract

Patients with inoperable non-small cell lung cancer, limited disease, were randomized to either chemotherapy (cisplatin and etoposide) or radiotherapy of the thorax. A set of questionnaires, covering 4 areas: psychosocial well-being, medical side effects, physical function, and everyday activity was filled out by 101 patients. The correlations between psychosocial well-being (dependent variable) on the one hand, and medical side effects, physical function, and everyday activity (independent variables) on the other were subjected to multiple regression analysis. No significant correlation was found between psychosocial well-being and chemotherapy- or radiotherapy-related subjective side effects. The disease-related symptoms correlated highly with psychosocial well-being during the observation period. Psychosocial well-being and the independent variables tended to be more strongly correlated during the follow-up period (14-52 weeks) than during the treatment period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852948     DOI: 10.3109/02841868809094368

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

Review 1.  Quality of life measurement for patients undergoing treatment for lung cancer.

Authors:  R J Fergusson; A Cull
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

Review 2.  Methods of assessing the effect of drug therapy on quality of life.

Authors:  P A Ganz
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  Students' Mental Health, Well-Being, and Loneliness during the COVID-19 Pandemic: A Cross-National Study.

Authors:  Tore Bonsaksen; Vivian Chiu; Janni Leung; Mariyana Schoultz; Hilde Thygesen; Daicia Price; Mary Ruffolo; Amy Østertun Geirdal
Journal:  Healthcare (Basel)       Date:  2022-05-27

4.  Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer.

Authors:  J B Sørensen; B Bergman; A L Nielsen; M Krarup; P Dombernowsky; H H Hansen
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.